The Middle East Cancer Consortium (MECC) is a regional initiative for cancer research and treatment. Established in 1996, MECC members include the United States, Cyprus, Egypt, Israel, Jordan, the Palestinian Authority, and Turkey. MECC aims to reduce the incidence and impact of cancer in the Middle East region through the solicitation and support of collaborative research and regional education. Its motto is: "Respect all people, collaborate in fighting human suffering, and help build a bridge for better understanding among all."[1][2][3]
- ^ Silbermann, Michael (2008). "The Middle East Cancer Consortium (MECC): A bridge to understanding between people". Bridges. 4: 4–7.
- ^ Silbermann, M; Dweib, Khleif A; Balducci, L (2010). "Healing by cancer". J. Clin. Oncol. 28 (8): 1436–1437. doi:10.1200/JCO.2009.24.8161. PMID 19917857.
- ^ Levin, A (June 3, 1998). "Middle East Cancer Consortium stays on track to collect data". J. Natl. Cancer Inst. 90 (11): 807–808. doi:10.1093/jnci/90.11.807. PMID 9625167.